Drug Information Journal

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Nursing, designed to support cutting-edge academic discovery.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• VigiBase, the WHO Global ICSR Database System: Basic Facts

  Citation: 447

  Authors: Marie

• The Use of Biological Assays to Evaluate Botanicals

  Citation: 308

  Authors: Jerry L., Lingling L., Jon E.

• Evaluation of the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets-1960 to 1999

  Citation: 306

  Authors: Man, Anna, Kathy, Jasmanda Hsiao-Hui, Ken, Edmundo

• Patient-Reported Outcomes: The Example of Health-Related Quality of Life—a European Guidance Document for the Improved Integration of Health-Related Quality of Life Assessment in the Drug Regulatory Process

  Citation: 285

  Authors: Olivier, Pierre, Patrick, Steve, Neil

• Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials

  Citation: 254

  Authors: Craig H., Peter W., Dan, Yahong, James P.

• Assessment of Dose Proportionality: Report from the Statisticians in the Pharmaceutical Industry/Pharmacokinetics UK Joint Working Party

  Citation: 232

  Authors: Kevin, Michael, Oliver, Bill, Stuart, Larry, John

• Practical Guidelines for Assessing the Clinical Significance of Health-Related Quality of Life Changes within Clinical Trials

  Citation: 191

  Authors: Jeff, Tara, Delfino, Brooke

• The Application of the Principle of Intention–to–Treat to the Analysis of Clinical Trials

  Citation: 180

  Authors: Dennis, Gary

• Type I Error Rates from Mixed Effects Model Repeated Measures Versus Fixed Effects Anova with Missing Values Imputed Via Last Observation Carried Forward

  Citation: 126

  Authors: Craig H., W. Scott, Stacy R.

• Adaptive Seamless Phase II/III Designs—Background, Operational Aspects, and Examples

  Citation: 121

  Authors: Jeff, Sumon, Vladimir, Paul, Michael